FORMULATION AND EVALUATION OF COLON TARGETED MATRIX TABLET USING NATURAL TREE GUMS
Objective: To develop a novel colon targeted tablet formulation using natural polysaccharides such as kondagogu gum and ghatti gum as carriers and diltiazem hydrochloride as a model drug.
Methods: The polymer-drug tablets were prepared by wet granulation technique, coated with two layers viz., inulin as an inner coat followed by shellac as outer coat and evaluated for properties such as average weight, hardness and coat thickness. In vitro release studies of prepared tablets were carried out for 2 h in pH 1.2 HCl buffer, 3 h in pH 7.4 phosphate buffer and 6 h in simulated colonic fluid (SCF) in order to mimic the conditions from mouth to colon.
Results: Percentage weight variation, percent friability and content of active ingredient for all the formulations were found to be well within United States Pharmacopoeia (USP) limits. Out of both the polymers, the tablets prepared with ghatti gum showed the maximum hardness of 7.1 kg/cm2. The FTIR spectra of pure diltiazem HCl and the formulation KF3 were found to be identical. From the DSC, it was evident that the melting point peak of diltiazem HCl and formulation KF3 were observed at 217.16 and 218.34 Â°C respectively. In vitro studies revealed that the tablets coated with shellac (2.5% w/w), prevented the drug release in stomach environment and inulin coated tablets (4% w/w) have limited the drug release in the small intestinal environment. The data obtained from in vitro drug release studies were fit into Peppas model and in all the cases the value of A was found to be more than 2, i.e., drug release by a combination of both diffusion and erosion-controlled drug release.
Conclusion: The study revealed that polysaccharides as carriers and inulin and shellac as a coating material can be used effectively for colon targeting of drugs for treating local as well as systemic disorders.
2. Abhishek B, Abhay SC. Argpyrimidine-tagged rutin-encapsulated biocompatible (ethylene glycol dimers) nanoparticles: application for targeted drug delivery in experimental diabetes (Part 2). Int J Pharm 2017;528:8-17.
3. Seth A, Jack EB, Vivek SD. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech 2015;16:731â€“41.
4. Valluru Ravi, Siddaramaiah Hatna, Pramod Kumar TM. Influence of natural polymer coating on novel colon targeting drug delivery system. J Mat Sci: Mater Med 2008;19:2131-6.
5. Pallab Roy, Aliasgar Shahiwala. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Controlled Release 2009;134:74-80.
6. Hata T, Shimazaki Y, Kagayama A, Tamura S, Ueda S. Development of a novel drug delivery system, time-controlled explosion system (TES). Part 5 Animal pharmacodynamic and human bioavailability studies. Int J Pharm 1994;110:1-7.
7. Watanabe S, Kawai H, Katsuma M, Fukui M. Colon-specific drug release system. U. S. Patent, 09/183339; 1998.
8. Takemura S, Watanabe S, Katsuma M, Fukui M. Human gastrointestinal transit study of a novel colon delivery system (CODES) using scintigraphy. Proceedings of the International Symposium on Controlled Release Bioactive Material; 2000. p. 27.
9. Katsuma M, Watanabe S, Kawai H, Takemura S, Masuda Y, Fukui M. Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm 2002;249:33â€“43.
10. Vinod VTP, Sashidhar R. Surface morphology, chemical and structural assignment of gum kondagogu (Cochlospermum gossypium D. C): an exudates tree gum of India. Indian J Nat Prod Resour 2010;1:181-92.
11. Janaki B, Sashidhar RB. Physico-chemical analysis of gum kondagogu (Cochlospermum gossypium): a potential food additive. Carbohydr Polym 2009;76:464-71.
12. Rathore HS, Sarubala M, Ramanathan G, Singaravelu S, Raja MD, Gupta S, et al. Fabrication of biomimetic porous novel sponge from gum kondagogu for wound dressing. Mater Lett 2016;177:108-11.
13. Vinod VTP, Sashidhar RB. Solution and conformational properties of gum kondagogu (Cochlospermum gossypium)â€“a natural product with immense potential as a food additive. Food Chem 2009;116:686-92.
14. Swati Malik, Ashok Kumar, Munish Ahuja. Synthesis of gum kondagogu-g-poly (N-vinyl-2-pyrrolidone) and its evaluation as a mucoadhesive polymer. Int J Biol Macromol 2012;5:756-62.
15. Valluru Ravi, Pramod Kumar TM. Investigation of kondagogu gum as a pharmaceutical excipient: a case study in developing a floating matrix tablet. Int J PharmTech Res 2013;5:70-8.
16. Ashok Kumar, Munish Ahuja. Carboxymethyl gum kondagoguâ€“chitosan polyelectrolyte complex nanoparticles: preparation and characterization. Int J Biolog Macromol 2013;62:80-4.
17. Vinod VTP, Sashidhar RB, Sarma VUM, Vijaya Saradhi UVR. Compositional analysis and rheological properties of gum kondagogu (Cochlospermum gossypium): a tree gum from India. J Agric Food Chem 2008;56:2199â€“207.
18. Gurpreet A, Malik K, Rana V, Singh I. Gum ghatti-a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone. Acta Pol Pharm 2012;69:725-37.
19. Valluru Ravi, Pramod Kumar TM, Siddaramaiah. Investigation of ghatti gum as a carrier to develop sustained release floating tablets of diltiazem hydrochloride. Thai J Pharm Sci 2012;36:155-64.
20. Cushman DR, Schick JW. Modified natural gums, U. S. Patent US 3891620; 1975.
21. Arvind KJ, Vishesh S, Meghali B, Rajesh V, Dhirendra SK. Electrosprayed inulin microparticles for microbiota triggered targeting of colon. Carbohydr Polym 2014;112:225-34.
22. Al-Gousous J, Penning M, Langguth P. Molecular insights into shellac film coats from different aqueous shellac salt solutions and effect on the disintegration of enteric-coated soft gelatin capsules. Int J Pharm 2015;484:283-91.
23. Jose S, Prema MT, Chacko AJ, Cinu TA, Souto EB. Colon-specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids Surf B 2011;83:277-83.
24. Joao MM Leitao, Joaquim CG, Esteves da Silva. Factorial analysis optimization of a Diltiazem kinetic spectrophotometric quantification method. Anal Chim Acta 2008;609:1-12.
25. Udaya ST, Tejraj MA. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride. J Controlled Release 2004;95:567-77.
26. Hee JP, Hyuck JJ, Myoung JH, Dae RL, Ha RC, Yong SC, et al. Colon-targeted delivery of solubilized bisacodyl by the doubly enteric-coated multiple-unit tablet. Eur J Pharm Sci 2017;102:172-9.
27. Rama Prasad YV, Krishnaiah YSR, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Controlled Release 1998;51:281-7.
28. Hideyuki Tozaki, Junta Komoike, Chika Tada, Takako Maruyama, Akira Terabe, Sutomu Suzuki, et al. Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016-21.
29. Sachin Kumar Singh, Ankit Kumar Yadav, Prudhviraj G, Monica Gulati, Puneet Kaur, Yogyata Vaidya. A novel dissolution method for evaluation of polysaccharide-based colon-specific delivery systems: a suitable alternative to animal sacrifice. Eur J Pharm Sci 2015;73L:72-80.
30. Peppas NA. Analysis of Fickian and non-fickian drug release from polymers. Pharm Acta Helvetiae 1985;60:110-1.